Daniel D. Long
SVP, Drug Discovery · 5 filings · Latest: Sep 1, 2026
Septerna, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SEPN | DANIEL LONG | — | Oct 1, 2026 | Proposed Sale | $39.13 | 10,001 | $391.3K | — | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Sep 1, 2026 | Sale | $37.83 | 3,333 | $126.1K | 96,412 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Sep 1, 2026 | Option Exercise | $2.76 | 3,333 | $9.2K | 99,745 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Aug 3, 2026 | Sale | $34.47 | 3,334 | $114.9K | 96,412 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Aug 3, 2026 | Option Exercise | $2.76 | 3,334 | $9.2K | 99,746 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Jul 1, 2026 | Sale | $34.36 | 3,333 | $114.5K | 96,412 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Jul 1, 2026 | Option Exercise | $2.76 | 3,333 | $9.2K | 99,745 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Jun 22, 2026 | Sale | $35.51 | 15,000 | $532.6K | 96,412 | |
SEPN | Daniel D. Long | SVP, Drug Discovery | Jun 22, 2026 | Option Exercise | $5.42 | 15,000 | $81.4K | 111,412 | |
SEPN | DANIEL LONG | — | Jun 22, 2026 | Proposed Sale | $36.17 | 25,000 | $904.3K | — | |
SEPN | DANIEL DAVID LONG | — | Nov 10, 2025 | Proposed Sale | $18.06 | 3,501 | $63.2K | — |